For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Report Scope:
This report is a comprehensive study of the global market for cholesterol testing. It describes the cholesterol tests market, which is segmented by product type and region. Based on product type, the market is segmented into lipid profile, total cholesterol tests, HDL tests, LDL tests, triglycerides tests and POCT. The market is segmented by region into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
This report examines the factors driving growth in the global cholesterol tests market, as well as reviews major players, established companies and new entrants.
This report, however, does not cover quality control reagents, calibrators, analytical equipment, instruments, software, and accessories used in cholesterol testing.
Report Includes:
- 22 tables
- An overview of the global cholesterol tests market
- Estimation of the market size and analyses of the global market trends, with data from 2019-2021, with projection of CAGR through 2026
- Coverage of risk indicators in major countries, prevalence of obesity and hypertension and information on mean total cholesterol level
- Description of different types of cholesterol tests such as lipid profile, total cholesterol tests, high density lipoprotein (HDL) tests, low density lipoprotein (LDL) tests, triglycerides tests, and discussion on their current and historical market revenues
- Analysis of new opportunities, challenges, and technological changes within the industry
- Detailed analysis of the current market trends and forecast, new products launches and product enhancement, and technological innovations of the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players in the market, including Abbott Laboratories, F. Hoffmann-La Roche Ltd., Nova Biomedical, Siemens Healthineers GmbH, Sekisui Diagnostics LLC, and ThermoFisher Scientific Inc.
Summary:
The global cholesterol tests market was valued at $REDACTED billion in 2020. The market is expected to reach $REDACTED billion by 2026, growing at a compound annual growth rate (CAGR) of REDACTED% over the forecast period. Growth factors include aging populations, increased disorders associated with aging, and obesity linked to heart disease, hypertension and diabetes. Technological innovations in cholesterol testing are driving increased use of cholesterol tests, which also is pushing market growth.
In 2020, the COVID-19 pandemic led to the temporary cessation of routine diagnostic procedures, including cholesterol testing, in hospitals, clinics and diagnostic centers worldwide. However, these procedures have resumed in the second half of 2021, which is driving growth in the global market for cholesterol tests.
In 2020, the lipid profile segment held the largest share of the global market for cholesterol tests with REDACTED%, followed by total cholesterol tests (REDACTED%), HDL tests (REDACTED%), POC tests (REDACTED%), triglycerides (REDACTED%) and LDL tests (REDACTED%).